1-Benzyl-1,2,3,4-tetrahydro-isoquinoline

1-Benzyl-1,2,3,4-tetrahydro-isoquinoline is an endogenous metabolite present in Cerebrospinal_Fluid that can be used for the research of Parkinson's Disease[1][2].

Product Specifications

CAS Number

[19716-56-4]

UNSPSC

12352005

Hazard Statement

H315-H319-H335

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Solubility

10 mM in DMSO

Smiles

C(NCC1)(CC2=CC=CC=C2)C3=C1C=CC=C3

Molecular Formula

C16H17N

Molecular Weight

223.31

Precautions

P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501

References & Citations

[1]Kotake Y, et al. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem. 1995 Dec;65 (6) :2633-8. |[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.